Document:

ex_273580.htm

 

Exhibit 10.01

 

2014 EMPLOYMENT AGREEMENT

 

 

This EMPLOYMENT AGREEMENT (this “Agreement”) is entered into as of July 14, 2014 (the “Effective Date”), by and between collectively, India Globalization Capital, Inc., (“IGC”) a corporation organized under the laws of Maryland, India Globalization Capital Mauritius, (“IGC-M” and collectively with IGC, “Employer”), and Ram Mukunda (“Executive”) on the following terms and conditions:

 

RECITALS:

 

A. The Employer desires to be assured of the continued services of Executive; and

 

B. Executive desires to continue to be employed by the Employer as its Executive Chairman and Chief Executive Officer upon the terms, covenants and conditions hereinafter set forth.

 

NOW, THEREFORE, in consideration of the mutual terms, covenants and conditions hereinafter set forth, the parties hereto agree as follows:

 

1. Employment Period.  Employer hereby agrees to continue to employ Executive as its Executive Chairman and Chief Executive Officer, and Executive, agrees to accept such continued employment for the period beginning on the Effective Date and ending on the fifth anniversary of the Effective Date (the “Employment Period”). Thereafter, Executive’s employment shall continue until terminated in accordance with this Agreement.

 

2. Performance of Duties.

 

	
			2.1.  

				
			Executive agrees that during the Employment Period, and while Executive is employed by Employer, he shall devote his full normal and customary working time, energies and talents exclusively to serving in the capacity of Chief Executive Officer of Employer and to performing such other duties consistent with his position, as may be properly assigned to him by the Board of Directors of Employer (the “Board”). He will carry out such duties faithfully, efficiently and in a professional manner.

			

 

	
			2.2.  

				
			In addition to the limitations imposed upon Executive by the Restrictive Covenants contained in Section 4, Executive shall not during the Employment Period and while he is employed by the Employer, without prior written consent from the Board:

			

 

	
			2.2.1.  

				
			serve as, be a consultant to or employee, officer, manager, agent, or director of, any corporation, partnership or other entity other than Employer (other than civic, charitable, or other public service organizations) if, as determined at the reasonable discretion of the Board, such service, employment, or position would have a material adverse effect upon the ability of Executive to perform his duties hereunder and Executive is so advised in writing and given a period of not less than ninety (90) days to cease; or

			

 

	
			2.2.2.  

				
			have more than a ten percent (10%) ownership interest in any enterprise other than Employer if such ownership interest would have a material adverse effect upon the ability of Executive to perform his duties hereunder, and the Executive is so advised in writing and given a period of not less than ninety (90) days to divest the interest.

			

 

3. Compensation.  Subject to the terms and conditions of this Agreement, Executive shall be compensated by Employer for his services as follows:

 

	
			3.1.  

				
			Executive shall receive, for each consecutive twelve (12) month period beginning on the Effective Date and ending on each anniversary thereof, a rate of pay equal to Three Hundred Thousand Dollars ($300,000.00) per year (“Base Pay”).  Such compensation shall be payable in substantially equal monthly or more frequent installments and subject to customary tax withholding.

			

 

	
			3.2.  

				
			Executive shall be entitled to participate in all executive benefit plans maintained by Employer on substantially the same terms and conditions as other executives of Employer including, but not limited to, plans as mentioned in Attachment 1.

			

 

 

 

 

	
			3.3.  

				
			Executive shall receive at least fifteen (20) days paid vacation per year, provided, however, that such vacation shall be scheduled and taken in accordance with Employer’s standard vacation policies applicable to Employer’s other executives.  Executive shall also be entitled to all other holiday and leave pay generally available to Employer’s other executives.  Any vacation days not used in a twelve (12) month period shall accrue and carry over to subsequent years.

			

 

	
			3.4.  

				
			Executive shall receive at least fifteen (15) days paid sick leave per year.  Any sick leave not used in a twelve (12) month period shall not accrue or carry over to subsequent years.

			

 

	
			3.5.  

				
			Executive shall be reimbursed by Employer for all reasonable business, promotional, travel and entertainment expenses incurred or paid by Executive during the Employment Period in the performance of his services under this Employment Agreement.

			

 

4. Restrictive Covenants.  Executive acknowledges and agrees that:

 

	
			4.1.  

				
			The agreements and covenants contained in this Section 4 are essential to protect the business interests of Employer and Employer will not enter into this Agreement but for such agreements and covenants. Accordingly, Executive covenants and agrees to the following:

			

 

	
			4.1.1.  

				
			Confidential Information.  Except as may be required by the lawful order of a court, regulatory body or similar agency of competent jurisdiction, and at the sole cost and expense of the Employer, if any, unless disclosed with the Employer’s permission, Executive agrees to keep secret and confidential, during the Employment Period and while he is employed by Employer, all confidential non-public information of Employer, and its respective affiliates that was acquired by, or disclosed to, Executive during the course of his employment by Employer or any of its affiliates, including information relating to customers (including, without limitation, credit history, repayment history, financial information and financial statements), costs, operations, financial data and plans, and employee information, whether past, current or planned, and not to disclose the same, either directly or indirectly, to any other person, firm or business entity, or to use it in any way; provided, however, that the provisions of this Section 4.1.1 shall not apply to information that:  (A) was, is now, or becomes generally available to the public (but not as a result of a breach of any duty of confidentiality by which Executive is bound); (B) was disclosed to Executive by a third party not subject to any duty of confidentiality to Employer prior to its disclosure to Executive; (C) is disclosed by Executive in the ordinary course of Employer’s business as a proper part of his employment in connection with communications with customers, vendors and other proper parties, provided that it is for a proper business purpose solely for the benefit of Employer.  During the Employment Period and while he is employed by Employer, Executive further agrees that he shall not make any statement or disclosure that is intended by Executive to be detrimental to Employer or any of its affiliates.

			

 

	
			4.1.2.  

				
			Non-Competition.

			

 

	
			4.1.2.1.  

				
			Executive agrees that for the period commencing on the Effective Date and ending on the date on which Executive’s employment with Employer is terminated for any reason or no reason (the “Non-Competition Period”), Executive shall not directly or indirectly, alone or as a partner, officer, director, manager, employee, consultant, agent, independent contractor, member or stockholder of any person or entity (“Person”), engage in any business activity in India or the United States that is directly or indirectly in competition with the Business (as defined herein) of Employer or which is known by Executive to be detrimental to the Business or business plans of Employer or its affiliates; provided, however, that the record or beneficial ownership by Executive or his immediate family members of five percent (5%) or less of the outstanding publicly traded capital stock of any company for investment purposes shall not be deemed to be in violation of this Section 4.1.2.1 so long as Executive is not an officer, director, manager, employee or consultant of such Person.  The “Business” of Employer shall mean infrastructure building in India.  Executive further agrees that during the Non-Competition Period, he shall not in any capacity, either separately or in association with others:  (1) employ or solicit for employment or endeavor in any way to entice away from employment with Employer or its affiliates (a) any current employee of Employer or its affiliates or (b) any Person who was employed by Employer or its affiliates in any preceding 12-month period; (2) solicit, induce or influence any supplier, customer, agent, consultant or other Person that has a business relationship with Employer to discontinue, reduce or modify such relationship with Employer; nor (3) solicit or enter into negotiations with any of Employer’s identified potential acquisition candidates.

			

 

	
			4.1.2.2.  

				
			Executive understands that the foregoing restrictions may limit his ability to engage in a business similar to Employer’s Business for the duration of the Non-Competition Period, but acknowledges that he will receive sufficiently high remuneration and other benefits to justify such restriction as an employee of Employer pursuant to this Agreement.

			

 

 

 

 

	
			4.1.2.3.  

				
			Notwithstanding the generality of any other provision of this Agreement, during the Non-Competition Period, it shall not be a violation of Section 2.2 or this Section 4 for Executive to (i) be an owner, partner, officer, director, manager, employee, consultant, agent, independent contractor, member or stockholder of any person or entity that does not compete with the Business of Employer or (ii) make unlimited investments with other family members in any person or entity that does not compete with the Business of Employer.

			

 

	
			4.1.3.  

				
			Remedies.  If Executive breaches any of the provisions contained in Sections 4.1.1 or 4.1.2 (the “Restrictive Covenants”), Employer shall have the following rights and remedies, each of which shall be enforceable, and each of which is in addition to, and not in lieu of, any other rights and remedies available to Employer at law or in equity.

			

 

	
			4.1.3.1.  

				
			Executive shall account for and pay over to Employer all compensation, profits, and other benefits which inure to Executive’s benefit which are derived or received by Executive or any person or business entity controlled by Executive, resulting from any action or transactions constituting a breach of any of the Restrictive Covenants.

			

 

	
			4.1.3.2.  

				
			Notwithstanding the provisions of Section 4.1.3.1 above, Executive acknowledges and agrees that in the event of a violation or Executive’s threatened violation of any of the Restrictive Covenants, Employer shall have no adequate remedy at law and shall therefore be entitled to enforce each such provision by temporary or permanent injunction or mandatory relief obtained in any court of competent jurisdiction without the necessity of proving damages, posting any bond or other security, and without prejudice to any other rights and remedies that may be available at law or in equity.

			

 

	
			4.1.4.  

				
			Severability.  If any of the Restrictive Covenants, or any part thereof, are held to be invalid or unenforceable, the same shall not affect the remainder of the covenant or covenants, which shall be given full effect, without regard to the invalid or unenforceable portions. Without limiting the generality of the foregoing, if any of the Restrictive Covenants, or any part thereof, are held to be unenforceable because of the duration of such provision or the area covered thereby, the parties hereto agree that the court making such determination shall have the power to reduce the duration and/or area of such provision and, in its reduced form, such provision shall then be enforceable.

			

 

	
			4.1.5.  

				
			Proprietary Rights.  Executive acknowledges and agrees that all know-how, documents, reports, plans, proposals, marketing and sales plans, client lists, employee files, client files, and any materials made by Executive or by Employer during the period of Executive’s employment are the property of Employer and shall not be used by Executive in any way adverse to Employer’s interests while he is so employed by Employer.

			

 

5. Termination and Compensation Due Upon Termination.  Executive’s right to compensation for the period after the date Executive’s employment with Employer terminates shall be determined in accordance with the following:

 

	
			5.1.  

				
			Termination Without Cause.  In the event Employer terminates Executive’s employment during the Employment Period without Cause, or at the end of the term, does not renew the Employment Agreement on substantially the same terms, Employer shall pay Executive compensation, incentive compensation and benefits as specified in Section 3 through thirty six (36) months during which time Executive shall be entitled to:

			

 

	
			5.1.1.  

				
			receive payment of his salary in accordance with the provisions of Section 3;

			

 

	
			5.1.2.  

				
			continued participation in the benefit plans of Employer as specified in Section 3 at Employer’s expense.

			

 

	
			5.2.  

				
			Voluntary Resignation.  Executive may terminate his employment with Employer for any reason (or no reason at all) at any time by giving Employer ninety (90) days prior written notice of voluntary resignation; provided, however, that Employer may decide that Executive’s voluntary resignation be effective immediately upon notice of such resignation. Employer shall have no obligation to make payments to Executive in accordance with the provisions of Section 3 for periods after the date on which Executive’s employment terminates due to Executive’s voluntary resignation, including in the event Employer accelerates the effectiveness of the resignation in accordance with this Section 5.2.  The non-competition clause as outlined in Section 4.1.2 shall apply for a period of 6 months following the effective date of the voluntary resignation.

			

 

	
			5.3.  

				
			However, for purposes of this Section 5, if Executive resigns within one hundred and twenty (120) days following the occurrence of one of the following events, Executive shall be deemed to be Terminated without Cause in accordance with Section 5.1:

			

 

	
			5.3.1.  

				
			Executive’s duties are materially reduced from those described in Section 2;

			

 

	
			5.3.2.  

				
			the relocation of Executive’s office more than twenty five (25) miles from Bethesda, Maryland without Executive’s consent;

			

 

	
			5.3.3.  

				
			a material breach of any of the provisions of this Agreement by the Employer.

			

 

	
			5.3.4.  

				
			a change of control of IGC.

			

 

 

 

 

	
			5.4.  

				
			Termination for Cause.  Employer shall have no obligation to make payments to Executive in accordance with the provisions of Section 3 or otherwise for periods after Executive’s employment with Employer is terminated because of Executive’s termination for Cause. For purposes of this Section 5.4, Executive shall be considered terminated for “Cause” if he is discharged by Employer on account of the occurrence of one or more of the following events:

			

 

	
			5.4.1.  

				
			Executive becomes habitually addicted to drugs or alcohol, as confirmed by the written opinion of a medical doctor;

			

 

	
			5.4.2.  

				
			Executive intentionally discloses confidential information in violation of Section 4.1.1 or engages in any action in violation of Section 4.1.2.

			

 

	
			5.4.3.  

				
			Employer is directed by regulatory or governmental authorities to terminate the employment of Executive or Executive intentionally engages in activities that cause actions to be taken by regulatory or governmental authorities that have a material adverse effect on Employer;

			

 

	
			5.4.4.  

				
			Executive is convicted of a felony crime (other than a felony resulting from a minor traffic violation);

			

 

	
			5.4.5.  

				
			Executive flagrantly disregards his duties under this Agreement after (A) written notice has been given to Executive by the Board that it views Executive to be flagrantly disregarding his duties under this Agreement and (B) Executive has been given a period of thirty (30) days after such notice to cease such misconduct.  However, no notice or cure period shall be required hereunder if Executive’s disregard of his duties has materially and adversely affected Employer or is illegal;

			

 

	
			5.4.6.  

				
			Executive commits an act of fraud against Employer, violates a duty of loyalty to Employer, or violates an obligation owed to Employer pursuant to Sections 2 or 4 hereof.

			

 

	
			5.5.  

				
			In the event Employer attempts to terminate Executive’s employment pursuant to Section 5.3 and it is ultimately determined that the Employer lacked Cause, the provisions of Section 5.1 shall apply and, in addition to any other remedies that Executive may have, Executive shall be entitled to receive the payments called for by Section 5.1 with interest on any past due payments at the rate of ten percent (10%) per year from the date on which the applicable payment would have been made, plus Executive’s costs and expenses (including but not limited to reasonable attorneys’ fees) incurred in connection with such dispute and interest thereon at the rate of ten percent (10%) per year from the date incurred by the Executive.

			

 

	
			5.6.  

				
			Employer shall have no obligation to make payments to Executive in accordance with the provisions of Section 3 for periods after the date of Executive’s death, except payments due and owing as of such date.

			

 

6. Indemnification.  Executive shall be defended, held harmless by and indemnified by Employer to the fullest extent permitted by applicable law (including, but not limited to payment of all legal fees and costs and by counsel reasonably satisfactory to him) against claims asserted against him by third parties, arising out of, or related to, the business of the Employer or Executive’s services for Employer or its affiliates, where such services were within the scope of authority of Employee, or specifically authorized in advance by Employer.  However, Employer shall have no obligation to defend, indemnify or hold Executive harmless from any claims relying in whole or in part upon any intentionally tortious, grossly negligent or fraudulent conduct by Executive.  This duty of indemnification shall survive the termination of this Agreement for a period of two years and is intended to be in addition to and not in lieu of any indemnification right of Executive that may be contained in the Bylaws or Articles of Incorporation of Employer.

 

7. Assignment and Successors.  This Agreement is personal in its nature and neither of the parties shall, without the written consent of the other, which may be given or withheld in the absolute discretion of each, assign, delegate or otherwise transfer this Agreement or any rights or obligations hereunder; provided, however, that in the event of a merger, consolidation, transfer or sale of all or substantially all of the assets or other reorganization of the Employer with or to any other individual(s) or entity, this Agreement shall, subject to the provisions hereof, be binding upon and inure to the benefit of such successor and such successor shall discharge and perform all the promises, covenants, duties and obligations of the Employer hereunder; provided, however, Employer shall continue to remain obligated hereunder.

 

8. Governing Law.  This agreement will be governed by and construed in accordance with the laws of the state of Maryland without reference to the principles of conflicts of laws or any other principle that could result in the application of the laws of any other jurisdiction. Any suit, action or proceeding arising out of or relating to this agreement must be instituted in the state or federal courts located in the state of Maryland, to the jurisdiction of which each of the parties hereby expressly and irrevocably agrees to submit. The parties agree to enter into mediation prior to trial in any suit, action, or proceeding arising out of or relating to this agreement.

 

 

 

 

9. Entire Agreement.  This Agreement embodies the entire agreement of the parties respecting the matters within its scope. This Agreement supersedes all prior agreements of the parties on this subject matter . Any prior negotiations, correspondence, agreements, proposals or understandings relating to the subject matter shall be deemed to be merged into this Agreement and to the extent inconsistent herewith, such negotiations, correspondence, agreements, proposals or understandings shall be deemed to be of no force or effect. There are no representations, warranties or agreements, whether express or implied, or oral or written, with respect to the subject matter , except as set forth herein.

 

10. Modifications.  This Agreement shall not be modified by any oral agreement, either express or implied, and all modifications shall be in writing and signed by the parties.

 

11. Waiver.  Failure to insist upon strict compliance with any of the terms, covenants or conditions shall not be deemed a waiver of such terms, covenant or condition, nor shall any waiver or relinquishment of, or failure to insist upon strict compliance with, any right or power at any one or more times be deemed a waiver or relinquishment of such right or power at any other time or times. All waivers shall be in writing and signed by Executive and Employer.

 

12. Number and Gender.  Where the context requires, the singular shall include the plural, the plural shall include the singular, and any gender shall include all other genders.

 

13. Headings.  The section and Section headings in this Agreement are for the purpose of convenience only and shall not limit or otherwise affect any of its terms .

 

14. Waiver of Jury Trial.  The parties acknowledge that they are hereby waiving any right to trial by jury in any action, proceeding or counterclaim brought by either of the parties against the other in connection with any matter whatsoever arising out of or in any way connected with this Agreement or Executive’s Employment.

 

15. Attorneys’ Fees.  Executive and the Employer agree that in any dispute resolution proceedings arising out of this Agreement, the prevailing party shall be entitled to its or his reasonable attorneys’ fees and costs incurred by it or him in connection with resolution of the dispute, in addition to any other relief granted.

 

16. Severability.  In the event that it is determined that any portion of this Agreement is in violation of any statute or public policy, then only the portions of this Agreement which violate such statute or public policy shall be stricken, and all portions of this Agreement which do not violate any statute or public policy shall continue in full force and effect. Furthermore, any determination striking any portion of this Agreement shall be done as narrowly as possible so as to give as much effect as possible to the intentions of the parties under this Agreement.

 

17. Counterparts.  This Agreement may be executed in any number of counterparts, each of which shall be deemed an original and all of which together shall constitute one and the same document .

 

18. Notices.  All notices and other communications provided for in the Agreement shall be in writing and will be deemed duly given (a) when delivered by hand or electronic mail, (b) two (2) days after being given to an express courier with a reliable system for tracking delivery, (c) when sent by confirmed facsimile with a copy sent by another means specified in this provision or (d) five (5) days after the day of mailing, when mailed by registered or certified mail, return receipt requested, postage prepaid, and addressed as set forth below. A party may from time to time change its address or designee for notification purposes by giving the other written notice of the new address or designee and the date upon which it will become effective. The addresses for such notices shall be:

 

18.1.     if to Executive:     

8909 Tuckerman Lane

Potomac, Md.  20854

Attention:  Ram Mukunda

 

with a copy to:

 

18.2.     If to Employer: 

P. O. BOX 60642

Potomac, Md. 20859

Attention:  Board

 

19. Time of the Essence.  Time is expressly made of the essence with respect to each and every provision of the Agreement.

 

20. Inurement.  Except as otherwise specified herein, no Person, other than the parties (and Executive’s estate upon his death, including his personal representative, administrator or heirs), shall have any rights under or interest in this Agreement or its subject matter.

 

 

[SIGNATURE PAGE FOLLOWS]

 

 

 

 

IN WITNESS WHEREOF, the undersigned have executed this Employment Agreement as of the Effective Date.

 

 

IGC

 

 

 

By: /s/ Richard Prins                                                           /s/ Ram Mukunda                     

Name: Richard Prins                                                           Ram Mukunda

Title:  Chairman

 

 

 

 

 

ATTACHMENT 1:

 

 

The terms set out in Section 3 are subject to annual review and update by the Board of IGC:

 

Section 3.5:   The Employer shall provide the Executive with an automobile, plus gas and maintenance expenses, to be used by Executive in connection with the performance of his duties for Employer.  Monthly lease payments, for the Employer, for such automobile shall not exceed $950 per month.  The Employee shall reimburse the Employer $125 per month for personal use of the automobile.  The Employer shall also provide the Executive with indemnity to the fullest extent permitted by law, reimbursement of business expenses, executive and personal assistant, domestic help, driver, cook, life insurance, health insurance, retirement benefits, deferred compensation, disability insurance, travel insurance, directors and officers insurance, and others as may be necessary from time to time.Exhibit 10.2

    

    
      SEPARATION AGREEMENT AND RELEASE

       

      THIS SEPARATION AGREEMENT AND RELEASE (the “Agreement”) is made and entered into by and between Dr. James Mond (hereafter “Employee”)
        and ADMA Biologics, Inc. on behalf of itself and each of its subsidiaries, affiliates, divisions, predecessors, successors, and assigns (hereinafter referred to collectively as the “Company” or “ADMA Biologics”).

      

      

      Pursuant to the terms and conditions set forth herein and in consideration of the premises and mutual promises contained herein, it is
        agreed by and between Employee and the Company as follows:

      

      

      1.           Separation Date:  Employee’s last date of employment with ADMA Biologics was June 8, 2021 (the “Separation Date”).  Employee agrees and
          represents that from and after the Separation Date, Employee will not be, nor will Employee hold himself out as, an employee, consultant, affiliate or agent of ADMA Biologics. While not an employee of ADMA Biologics after the Separation Date,
          Employee agrees to abide by the confidentiality and other obligations of this Agreement as set forth herein.

       

      

      2.         Separation Benefits:  In consideration of the releases and covenants given by Employee as set forth in this Agreement and Employee’s
          compliance therewith, and provided that Employee signs and does not revoke this Agreement and further complies with its terms and conditions, ADMA Biologics agrees as follows:

      

      

      (a)        Salary Continuation:  For a period of ten (10) months beginning on August 1, 2021 through May 1, 2022 (the “Severance Period”), the Company will pay Employee
          on a monthly basis the equivalent of his monthly base salary subject to the tax withholdings used prior to the Separation Date (the “Severance Payments”) paid on the regularly scheduled payroll dates.  The first Severance Payment will be made on
          the next regularly scheduled payroll date following the Effective Date of this Agreement. Severance Payments are contingent on Employee’s continued compliance with the terms of this Agreement including, but not limited to, cooperation pursuant to
          Section 8 below.

      

      

      (b)          Bonus Payment:  The Company will pay employee the total gross sum of $140,000.00, subject to the customary and ordinary tax withholdings, payable as follows:
          (1) $70,000.00 paid within 30 days of the Effective Date; and (2) $70,000.00 paid at the expiration of the Severance Period.

      

      

      (c)          Restricted Stock Unit Payment: Employee forfeits all unvested restricted stock units and in lieu thereof the Company shall pay Employee the total gross sum of
          $175,000.00 subject to the customary and ordinary tax withholdings, payable as follows: (1) 87,500.00 paid within 30 days of the Effective Date; and (2) $87,500.00 paid at the expiration of the Severance Period.

      

      

      (d)       Exercise Extension:  Employee shall have twenty-four (24) months to exercise any stock option vested as of the Effective Date of this Agreement.  All options
          remain otherwise subject to the terms and conditions of any plan document and/or grant agreement.

       

        

      
        1

        
          

      

      (e)       Repricing Participation:  In the event the Company’s Board of Directors approves a stock option exchange program or other repricing mechanism, then Employee’s
          vested stock options shall be, subject to the terms and conditions of the Company’s equity incentive plan, able to participate in any such program or repricing that occurs during the Severance Period.  The options are otherwise subject to the
          terms and conditions of any plan document and/or grant agreement.

      

      

      (f)          Expense Reimbursement: The Company agrees to reimburse Employee’s relocation expenses in the total gross sum $30,000.00, subject to the customary and ordinary
          tax withholdings, paid within 30 days of the Effective Date.

      

      

      (g)        Attorneys’ Fees:  The Company will pay Employee’s legal fees and costs incurred in negotiating this Agreement in the total gross sum of $15,000.00, payable
          within 30 days of the Effective Date of this Agreement by a check made payable to Neuberger Quinn Gielen Rubin Gibber P.A., One South Street, 27th Floor, Baltimore, MD 21202.  This payment will be reported as “miscellaneous” income on Forms 1099
          to be issued to Employee and Neuberger Quinn Gielen Rubin Gibber P.A.  Employee’s counsel will provide the Company with fully executed W-9s for Neuberger Quinn Gielen Rubin Gibber P.A and Employee.

      

      

      (h)        COBRA:  If Employee timely elects continued health coverage under the Consolidated Omnibus Budget Reconciliation Act (COBRA), the Company agrees to reimburse
          Employee the same employer premium percentage contribution in effect on the Separation Date through the Severance Period, provided Employee remains eligible for COBRA benefits and does not qualify for health coverage under another employer during
          this period.  Accordingly, Employee agrees to notify Company as soon as possible after Employee becomes eligible for health insurance coverage under another employer or ceases to be eligible for COBRA benefits.  Notwithstanding the foregoing, if
          the payments made by the Company under this Section 2(h) would violate the nondiscrimination rules or result in the imposition of penalties under the Patient Protection and Affordable Care Act of 2010 and related regulations and guidance, the
          parties agree to reform this Section 2(h) as necessary to ensure compliance.  Payment(s) under this Section will be made within fourteen (14) days of submission by Employee of proof of payment.

      

      

      (i)          Employee acknowledges
          that Employee would not be entitled to receive the consideration set forth in this Section 2 absent execution of this Agreement and agrees that the amount of the consideration set forth herein is greater than any amount Employee is otherwise
          entitled to receive from ADMA Biologics, Inc. and/or the Releasees (as that term is defined below) under any law, contract, policy, promise, expectation, or otherwise, either as compensation, wages, commissions, incentives, accrued but unused
          vacation or paid time off, severance, benefits, reimbursements, damages, or otherwise.  In the event the Internal Revenue Service, or any other state or local taxing entity, or any court or other tribunal of competent jurisdiction, determines
          that all or part of these payments are remuneration for which any taxes are due and owing by the Company, except the Company’s employer share/contribution, Employee shall be solely responsible for the payment of such taxes.  Employee agrees not
          to make a claim against the Company for the payment of any such taxes, or for any related interest or penalties.  Employee also agrees to indemnify the Company for any amounts paid, including, but not limited to, interest and penalties, in
          connection with any taxes that Employee may owe based on these payments.

       

        

      
        2

        
          

      

      3.           Business Expense Reimbursement:  The
          Company will reimburse Employee for all approved and documented business expenses incurred prior to the Separation Date, provided that Employee submits to the Company prior to the Effective Date, an expense report with adequate documentation of
          such expenses in accordance with the Company’s policies.

      

      

      4.           Other Rights and Benefits:  As of the Separation Date, Employee’s (i) accrual of paid time off, (ii) participation in any and all health,
          dental and prescription plans, and (iii) participation in any and all Life, AD&D, long term disability, and 401(k) retirement savings plans will terminate.  Employee’s execution of this Agreement shall not diminish any benefits vested
          pursuant to the terms of any Employee Retirement Income Security Act of 1974 (ERISA) employee pension or 401(k) benefit plan, which benefits shall continue to be subject to the terms of applicable plan documents.   The Company shall pay Employee
          for 33.75 hours of vacation/PTO.

      

      

      5.          Full Discharge of Obligations:  Employee understands and agrees that Employee is not entitled to, and will not receive, any payments or
          benefits of any kind (including but not limited to wages, bonus payments, incentive compensation payments, or other payments to which Employee otherwise might have been entitled) from the Company except as expressly set forth herein above.
          Employee further represents that Employee has or will receive all compensation, including salary payments, due and owing through the Separation Date.  In addition, Employee understands and agrees that after the Separation Date, Employee will not
          accrue any further benefits under any of the Company’s applicable plans.

      

      

      6.           Release:  As a material inducement to the Company to enter into this Agreement and to give Employee the benefits described above, Employee
          forever releases and discharges the Company and each of its predecessors, successors, assigns, partners, directors, officers, members, managers, stockholders, employees, representatives, attorneys, agents, divisions, subsidiaries, and affiliates
          (and the past and present partners, directors, officers, members, managers, stockholders, employees, representatives, attorneys and agents of such divisions, subsidiaries and affiliates), and all persons acting by, through, under, or in concert
          with any of them (hereinafter the “Releasees”), from any and all charges, complaints, claims, liabilities, obligations, promises, agreements, controversies, damages, actions, causes of action, suits, rights, demands, costs, losses, debts and
          expenses (including attorneys’ fees and costs actually incurred) of any nature whatsoever, in law or equity, known or unknown, suspected or unsuspected, that Employee and Employee’s issue, heirs, representatives, successors, agents, executors,
          administrators and assigns ever had, now has or hereafter can, shall or may have for, upon, or by reason of any matter, cause or thing whatsoever through the date of this Agreement, including but not limited to any claims arising out of his
          employment by the Company and the cessation of such employment; any claims for unpaid wages, back pay, bonuses, incentive pay, vacation pay, legal fees, severance or other compensation; any claims arising under any contracts, express or implied,
          or any covenant of good faith and fair dealing, express or implied; any tort, including without limitation intentional infliction of emotional distress, defamation, fraud and breach of duty; any legal restrictions on the Company’s right to
          terminate employees; and any federal, state, local, or other governmental common law, statute, regulation, or ordinance, including without limitation: Title VII of the Civil Rights Act of 1964, the Civil Rights Act of 1991, the Age Discrimination
          in Employment Act of 1967, the Older Workers’ Benefit Protection Act, the Genetic Information Nondiscrimination Act of 2008, the Worker and Adjustment Retraining Notification (“WARN”) Act, the Illinois WARN statutes, the New Jersey WARN statutes,
          the New Jersey Law Against Discrimination, the New Jersey Conscientious Employee Protection Act, the New Jersey Family Leave Act, the New Jersey Temporary Disability Benefits Law, the New Jersey Wage Payment Law, the New Jersey Wage and Hour Law,
          the New Jersey Workers’ Compensation Law, the Americans with Disabilities Act, the Florida Whistleblower Protection Act, the Florida Workers’ Compensation Retaliation provision, the Florida Minimum Wage Act, the Florida Constitution, the Florida
          Fair Housing Act, the Equal Pay Act, the Employee Retirement Income Security Act, the Rehabilitation Act of 1973, and the Family and Medical Leave Act of 1993, each of the foregoing as amended; provided, however, that nothing contained herein shall serve to waive any (a) claims or rights that, pursuant to law, cannot be legally waived or subject to a release of this kind, such as claims for
          unemployment or workers’ compensation benefits; (b) rights to vested benefits under any applicable retirement plans as of the Separation Date; (c) rights to vested stock options and rights arising under any stock option agreement and Company
          equity incentive plan; and/or (d) claims arising under or to enforce the terms of this Agreement. Moreover, nothing herein shall be construed to prohibit Employee from filing a charge with, or participating in any investigation or proceeding
          conducted by, the Equal Employment Opportunity Commission or a comparable state or local agency (“EEOC”); provided, however, that Employee agrees and covenants to waive his right to recover monetary damages in any such EEOC charge, complaint, or
          lawsuit filed by Employee or by any other person, organization, or other entity on Employee’s behalf with respect to the claims lawfully released by this Agreement.

       

        

      
        3

        
          

      

      7.            Representations:

      

      

      (a)          The Company represents
          and acknowledges that it is not aware of any claim, if any, that it may have against Employee as of the signing of this Agreement.

      

      

      (b)         Employee acknowledges
          that as an employee of the Company it has been Employee’s obligation to advise the Company completely and candidly of all facts of which Employee is aware that constitute or might constitute violations of the Company’s ethical standards or legal
          or regulatory obligations.  Employee represents and warrants that Employee is not aware of any such facts or that Employee has previously advised the Company about any such facts. Employee further agrees to advise the Company in the future of all
          such facts that come to Employee’s attention; and

      

      

      (c)         Employee, for himself
          and Employee’s issue, heirs, representatives, successors, agents, executors, administrators, and assigns, represents and warrants that, to the fullest extent permitted by law, Employee has not filed any complaints or charges or lawsuits against
          the Company with any governmental agency or court.

      

      

      8.            Cooperation:  Employee and the Company agree that certain matters in which Employee has been involved during his employment may require his
          cooperation with the Company in the future.  Accordingly, to the extent reasonably requested by the Company and to help ensure a smooth and honorable transition from the Company, during business hours for the duration of the Severance Period,
          Employee agrees to cooperate with the Company upon its reasonable request to provide assistance via telephone, e-mail or in-person meetings in connection with any matters in which Employee was involved while employed by the Company.  In
          particular, but without limitation, Employee agrees to make himself reasonably available via telephone, e-mail or in-person meetings during such period to the Company to respond to requests by the Company for information relating to scientific or
          intellectual property matters within the scope of Employee’s responsibility prior to the Separation Date, including with respect to Company patents, patent applications or other formal intellectual property related documents, any Company-related
          scholarly articles, any litigation, arbitration or governmental or regulatory inquiry or investigation, or similar proceeding, and to provide truthful testimony to any court, agency or other adjudicatory body.

       

        

      
        4

        
          

      

      9.            Confidentiality:  (a) Employee agrees not to disclose, divulge, publish, communicate, publicize, disseminate or otherwise reveal, either
          directly or indirectly, any Confidential Information (as defined below) to any person, natural or legal, who is not affiliated with the Company (i.e., employees, principal stockholders and directors), otherwise bound by an agreement with the
          Company or obligation of confidentiality for the benefit of the Company or in need of such information in connection with services to be provided for the benefit of the Company. The term "Confidential Information" means all information in any
          form relating to the past, present or future business affairs, including without limitation, research, development or business plans, operations or systems, of the Company or a person not a party to this Agreement whose information the Company
          has in its possession under obligations of confidentiality, which is disclosed by the Company to Employee or which is produced or developed while Employee is an owner of, employee or director of the Company. The term “Confidential Information”
          shall not include any information of the Company which becomes publicly known through no wrongful act of Employee or is received from a person not a party to this Agreement who is free to disclose it to Employee.  To the fullest extent permitted
          by law, Employee further agrees not to divulge to anyone (other than the Company or any persons employed or designated by ADMA Biologics), publish, or make use of any such Confidential Information without the prior written consent of the
          Company.  Employee (i) may make and retain electronic copies of his contact list and calendar and (ii) may retain any documentation relevant to and reasonably necessary to file his income tax returns.  Employee’s obligations in this Section are
          in addition to any of Employee’s continuing obligations under the Confidentiality, Non-Disclosure, E-Mail, Telephone, Fax and Computer Policy and Agreement, provided to Employee when Employee began employment with the Company (“Confidentiality
          and Non-Disclosure Agreement”), as well as the Company’s Insider Trading Policy which continuing obligations remain in full force and effect and are expressly incorporated herein.

      

      

      (b)          Nothing in this
          Agreement is intended to or shall preclude Employee from: (i) providing truthful testimony on any subject matter in response to a valid subpoena, court order, regulatory request or other judicial, administrative or legal process or otherwise as
          required by law, in which event Employee shall notify the Company of the anticipated testimony in writing, unless prohibited to do so by law, as promptly as practicable after receiving any such request and at least ten (10) business days prior to
          providing such testimony (or, if such notice is not possible under the circumstances, with as much prior notice as is possible) so that the Company may seek a protective order or other appropriate remedy; or (ii) reporting, without any prior
          authorization from, or notification to, the Company, possible violations of federal law or regulation to any governmental agency or entity, including but not limited to the Securities and Exchange Commission, the Department of Justice, Congress,
          and any agency Inspector General, or making other disclosures that are protected under the whistleblower provisions of federal law or regulation.  If such a protective order or other remedy described in clause (i) of the foregoing sentence is not
          obtained, or the Company waives compliance with this Agreement, Employee shall furnish only that portion of such subject matter that is legally required and shall exercise all reasonable efforts to obtain reliable assurance that confidential
          treatment will be accorded to the subject matter to be disclosed.

       

        

      
        5

        
          

      

      (c)          Employee is hereby
          further notified in accordance with the Defend Trade Secrets Act of 2016 that Employee will not be held criminally or civilly liable under any federal or state trade secret law for the disclosure of a trade secret that: (i) is made in confidence
          to a federal, state, or local government official, either directly or indirectly, or to an attorney, solely for the purpose of reporting or investigating a suspected violation of law; or (ii) is made in a complaint or other document filed in a
          lawsuit or other proceeding, if such filing is made under seal.

      

      

      (d)         Employee expressly
          agrees to keep secret and strictly confidential, the circumstances leading up to this Agreement except: (a) with the prior written consent of the Company; (b) to Employee’s attorney or tax preparers, provided such individuals are specifically
          instructed to maintain such information as confidential and agree to keep said information strictly confidential and not disclose it to others; or (c) as may be required by law, including in response to valid legal process or upon request by a
          government taxing authority or other government entity.  Moreover, this Agreement and its terms shall not be used or disclosed in any court, arbitration or legal proceedings, except to enforce the provisions of this Agreement, in which case the
          Agreement shall be filed under seal.  In the event that Employee is compelled to make disclosures related to any released party pursuant to a subpoena or other court process, or Employee has advance notice that a subpoena or other court process
          may result in the disclosure of confidential information, or Employee should reasonably conclude that a subpoena or other court process may result in the disclosure of Confidential Information, then Employee shall provide advance written notice
          of such compelled disclosure to the Company within sufficient time for the Company to object to disclosure.  The Employee expressly agrees and acknowledges that the Company may publicly disclose the existence and terms of this Agreement,
          including through the Company’s filings with the Securities and Exchange Commission.

      

      

      10.        Return of Company Property:  As of the Effective Date, Employee will have returned to the Company all
          Confidential Information, files, memoranda, and records, cardkey passes, door and file keys, computer access codes, software, corporate credit card, equipment, including cell phones and computers, and other property which he received, acquired,
          or prepared in connection with his employment with the Company, and any and all copies, duplicates, reproductions, synopses, and/or excerpts thereof (collectively, “Company Property”). Employee further agrees and certifies herein that by no later
          than the Effective Date, Employee has permanently and irrevocably deleted any and all intangible Company Property, including any Company emails or documents sent to, by or from any Company employee, including himself, which exists or is stored
          (i) in any e-mail account; (ii) in any “cloud” account; or (iii) on any computer, tablet, cellular phone or smartphone, the foregoing of which are accessible, controlled, or owned by him.  The consideration detailed in Section 2 above is
          contingent on Employee’s compliance with his obligations under this Section.

       

        

      
        6

        
          

      

      11.         Non-Disparagement:  Employee agrees not to directly or indirectly, or encourage others, to defame, disparage or criticize the Company, its
          business plan, procedures, products, services, development, finances, financial condition, capabilities or other aspect of its business, or any of its stockholders in any medium (whether oral, written, electronic or otherwise, whether currently
          existing or hereafter created), to any person or entity, without limitation in time. Nothing in this Agreement is intended to (a) preclude the Employee from making any truthful statement to the extent required by law or by any court, arbitrator,
          mediator or administrative or legislative body with actual or apparent jurisdiction to order such person to disclose or make accessible such information; or (b) unlawfully impair or interfere with Employee’s rights under Section 7 of the National
          Labor Relations Act.  The Company agrees to instruct Adam Grossman and Brian Lenz to not directly or indirectly, or encourage others, to defame or disparage Employee in any medium (whether oral, written, electronic or otherwise).  The parties
          understand that this provision is a material one.

      

      

      12.          Work Product Assignment: Employee
          hereby assigns to the Company all of his right, title and interest in and to, and shall disclose promptly to the Company, any and all work product, developments, processes, inventions, ideas and discoveries, and works of authorship developed,
          discovered, improved, authored, derived, invented or acquired by Employee during the period of his employment by the Company (collectively, "Work Product"), whether or not during business hours, that are either related to the scope of Employee 's
          employment by the Company or make use, in any manner, to the dedicated resources of the Company, and agrees that such Work Product shall be and shall remain the exclusive property of the Company. The parties hereto understand that the term Work
          Product includes, but is not limited to, all work product developed, discovered, improved, authored, derived, invented or acquired by Employee that: (i) incorporates or reflects any Confidential information, (ii) relates to the business of the
          Company or the Company's actual or anticipated research and development with respect to Confidential Information, or (iii) results from any work performed by Employee for the Company. Work Product shall not include anything relating to a
          potential transaction or matter which involves the business of the Company as then conducted (or is related thereto, or a business the Company is then contemplating entering) and may be an investment or business opportunity or of prospective
          economic or competitive advantage to the Company, with respect to which the Board of Directors of the Company has made a determination not to pursue.

      

      

      13.          Non-Competition: Employee absolutely
          and unconditionally covenants and agrees that, for the period commencing on the Separation Date through the period ending 12 months thereafter (the “Restrictive Period”), Employee will not, either directly or indirectly, solely or jointly with
          any other person or persons, as an employee, consultant or advisor, or as an individual proprietor, partner, stockholder, director, officer, joint venturer, investor, lender or in any other capacity (whether or not engaged in business for
          profit), engage or participate in a Competing Business (as defined below). Nothing herein contained shall, however, prohibit Employee’s acquisition or ownership of (i) stock or securities listed on a national or regional securities exchange or
          the Nasdaq Stock Market, so long as such investments, in the aggregate, in any particular business enterprise constitute less than five percent (5%) of the total issued and outstanding stock and securities of such enterprise or (ii) passive
          investment in units or other interests in private equity or hedge funds to similar investment vehicles. The term “Competing Business” means (i) the manufacture and sale of immune globulin intravenous (IGIV) and hyperimmune immunoglobulin (IG),
          (ii) plasma collection, (iii) the manufacture of plasma products competitive with products manufactured by or under development by the Company, (iv) the manufacture of vaccines to stimulate hyperimmune donors, and (v) any other specific business
          being conducted by the Company during the term of the Employee’s employment with the Company.  Nothing herein shall restrict the ability of any of the Permitted Entities, as such term is used in Employee’s Amended and Restated Employment
          Agreement (which is otherwise superseded), to continue the conduct of their existing businesses.

       

        

      
        7

        
          

      

      14.          Non-Solicitation:  Employee
          absolutely and unconditionally covenants and agrees that, during the Restrictive Period, Employee will not, either directly or indirectly, for any reason, whether for Employee’s own account or for the account of any other person, natural or
          legal, without the prior written consent of the Company: (i) solicit, employ, deal with or otherwise interfere with any contract or relationship of the Company with any employee, officer, director or any independent contractor of the Company,
          while such person or entity is employed by or associated with the Company or in the case of former employees within one year of the termination of such person's employment with the Company during the Restrictive Period, unless such person was
          terminated without cause by the Company, (ii) solicit, accept, deal with or otherwise interfere with any contract or relationship of the Company with any independent contractor, customer, client or supplier of the Company or with any person,
          natural or legal the effect of which would have an adverse effect on the Company, or (iii) solicit or otherwise interfere with any existing or proposed contract between the Company and any other person, natural or legal.  Other than responding to
          requests made pursuant to Section 8, Employee agrees not to contact or communicate with employees, directors or independent contractors of the Company except for personal reasons.  Without limitation to the foregoing, Employee may continue to
          work with any independent contractor, customer, client or supplier of the Company, or with any person, natural or legal, who or which has had a previous relationship with any of the Permitted Entities, as such term is used in Employee’s Amended
          and Restated Employment Agreement (which is otherwise superseded),  and which may continue to have such a relationship while honoring any commitments or obligations that it may have with the Company or with whom the Employee had a preexisting
          relationship prior to the Employee’s employment with the Company.

      

      

      15.          Indemnification:  The Company shall
          abide by any preexisting obligations to indemnify Employee pursuant to the Company Charter.

      

      

      16.          Rule of Ambiguities:  It is agreed and understood that the general rule that ambiguities are to be construed against the drafter shall not
          apply to this Agreement.  In the event that any language in this Agreement is found or claimed to be ambiguous, each party shall have the same opportunity to present evidence as to the actual intent of the parties with respect to any such
          ambiguous language without any inference or presumption being drawn against the drafter.

      

      

      17.          Severability:  It is the desire and intent of the parties that the provisions of this Agreement shall be enforced to the fullest extent
          permissible under the laws and public policies applied in each jurisdiction in which enforcement is sought.  In the event that any one or more of the provisions of this Agreement shall be held to be invalid, illegal or unenforceable, the
          validity, legality and enforceability of the remaining provisions shall not in any way be affected or impaired thereby.  Moreover, if any one or more of the provisions contained in this Agreement shall be held to be excessively broad as to
          duration, scope, activity or subject, such provisions shall be construed by limiting or reducing them so as to be enforceable to the maximum extent compatible with applicable law.

       

        

      
        8

        
          

      

      18.          Non-Admission of Liability:  This Agreement is not, and shall not in any way be construed as, an admission by the Company that it has acted
          wrongfully with respect to Employee or any other person, or that Employee has any rights whatsoever against the Company except as set forth herein.  The Company specifically disclaims any liability to or wrongful acts against Employee or any
          other person.

      

      

      19.          Representation:  Employee acknowledges that he was advised by the Company to consult with an attorney of his own choosing concerning the
          waivers contained in this Agreement, that Employee retained Thomas M. Wood IV, Esq., and that the waivers Employee has made herein are knowing, conscious, and with full appreciation that Employee is forever foreclosed from pursuing any of the
          rights so waived.

      

      

      20.         No Modification:  No waiver or modification of this Agreement or any term or provision hereof shall be binding unless it is in writing and
          signed by the parties hereto or their expressly authorized representatives.

      

      

      21.          Choice of Law; Dispute Resolution:  This Agreement shall be construed in accordance with the laws of the State of Florida without regard to
          conflicts of law principles.   Employee and the Company hereby submit to the exclusive jurisdiction of the state and federal courts located in Florida (and waive the defenses of lack of jurisdiction or inconvenient forum to the maintenance of any
          such action or proceeding in such venue) for any proceedings to obtain injunctive relief for a breach or threatened breach of any covenants herein.

      

      

      22.         Injunctive Relief:  Employee agrees and acknowledges that the Company will be irreparably harmed by any breach, or threatened breach, by
          Employee of this Agreement and that monetary damages would be grossly inadequate.  Accordingly, Employee agrees that in the event of a breach or threatened breach by Employee of this Agreement, the Company shall be entitled to immediate
          injunctive or other preliminary or equitable relief, as appropriate, in addition to all other remedies available at law and equity, without being required to post a bond.

      

      

      23.         No Disclosure:  Other than as may be required by law, Employee agrees not to disclose to anyone, other than Employee’s immediate family,
          accountant, and attorney, the contents of this Agreement, the circumstances surrounding it, or its terms, conditions, and negotiation, including the dollar amounts set forth herein, and then only upon their express agreement not to disclose such
          subject matter to another person, except as required by law.

      

      

      24.         Entire Agreement:  This Agreement sets forth the entire agreement between the parties hereto and fully supersedes and replaces any and all
          prior agreements, arrangements, or understandings (whether oral or written) between the parties hereto pertaining to the subject matter hereof.  Employee acknowledges and agrees that in signing this Agreement, Employee has not relied upon any
          representation, promise, or inducement that is not expressly set forth in this Agreement.  All prior written agreements between Employee and the Company remain in effect unless modified by the provisions herein.

       

        

      
        9

        
          

      

      25.         Revocation Period; Effective Date:  Employee shall have a period of twenty-one (21) days from the date on which a copy of this Agreement has
          been delivered to Employee to consider whether to sign it.  In the event that Employee elects to sign and return to the Company a copy of this Agreement, Employee has a period of seven (7) days following the date of Employee’s execution to revoke
          this Agreement (the “Revocation Period”) by delivering a written letter to ADMA Biologics, Inc., 5800 Park of Commerce Blvd., NW, Boca Raton, FL 33487, Attention: Kim Tripodo, Executive Director & Head of Human Resources, within the
          Revocation Period notifying ADMA Biologics of Employee’s revocation.  Employee further acknowledges and agrees that, in the event that Employee revokes this Agreement, the Agreement shall have no force or effect, and Employee shall have no right
          to receive any of the benefits provided for hereunder.  Provided that Employee signs and does not revoke the Agreement as set forth above, it shall become effective on the eighth (8th) day following Employee’s execution of this
          Agreement (the “Effective Date”).  Employee acknowledges and agrees that, in the event Employee does not sign this Agreement within such twenty-one (21) day period or revokes his consent during the additional seven (7) day period described above:
          (i) the Agreement shall have no force or effect and Employee’s last day of employment with the Company was the Separation Date.

      

      

      26.         Voluntary Execution:  Employee hereby acknowledges that Employee has read and that Employee understands the foregoing Agreement and that
          Employee has affixed their signature hereto voluntarily and without coercion.

      

      

      27.        Counterparts:  This Agreement may be executed in any number of counterparts, which together shall be effective as if they were a single
          document.  Signatures on the Agreement transmitted by email or facsimile copy shall have the same force and effect as original signatures.

      

      

      28.         Cost of Enforcement:  In the event of litigation involving this Agreement, the non-prevailing party shall reimburse the prevailing party for
          all costs and expenses, including reasonable attorneys’ fees and expenses, incurred in connection with any such litigation or arbitration, including any appeal therefrom.

      

      

      PLEASE READ CAREFULLY. THIS SEPARATION AGREEMENT AND RELEASE INCLUDES A RELEASE OF KNOWN AND UNKNOWN CLAIMS.

      

      

      	
              EMPLOYEE

            	 	
              ADMA Biologics, Inc.

            
	 	 	 	 	 
	
              By:

            	
              /s/ James Mond

            	 	
              By:

            	
              /s/ Adam Grossman

            
	 	 	 	 	 
	
              Name:

            	
              James Mond

            	 	
              Name:

            	
              Adam Grossman

            
	 	 	 	 	 
	
              Title:

            	 	 	
              Title:

            	
              President & CEO

            
	 	 	 	 	 
	
              Date:

            	
              August 4, 2021

            	 	
              Date:

            	
              August 6, 2021

            

      

      

      

      

      10

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00332-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00332-of-00352.parquet"}]]